Unilever Plc GSK Plc

2021 2020 2021 2020

ROIC 13.45% 13.56% 10.56% 12.36%
Net Margin 12.62% 11.97% 14.94% 18.73%
Current Ratio 0.70 0.78 0.79 0.91
Operating Cycle 94 92 266 261
Interest Coverage 17.72 11.41 7.91 8.73
Debt Ratio 0.7371 0.7391 0.7302 0.7413

Current
operati ngrati o
cycle
ROIC
Unilever
Unilever Plc
Plc GSK
GSK Plc
Plc
Unilever Plc GSK Plc 0.91
13.56%
266
13.45%

261
10.56% 0.79

0.78

12.36%
0.70

debt rati o
Unilever Plc GSK Plc
percentage
ratio

0.7413
days

0.7391
94

92
0.7371

2
2002
21 2
2002
20
ratio

1 0
0.7302

2021 2020
year
year
year

2021 2020

year
 Unilever Plc GSK
2021 2020 2021 2020 Net margin
Sales 52,444 50724 34114 34099
Unilever Plc GSK Plc
COGS 30259 28684 11603 11704
Net Profit 6621 6073 5096 6388
Tax 1935 1923 346 580
Interest 491 728 784 892

14.94%
EBIT 8702 8303 6201 7783
Asset 75095 67659 79103 80431

12.62%

11.97%
Equity 19746 17655 21342 20808
Debt 55349 50004 57761 59623

percentage
Long-debt 30571 29412 34091 37475
Capital 50317 47067 55433 58283
CA 17401 16157 18674 20247
CL 24778 20592 23670 22148
INV 4683 4462 5783 5996
TR 5422 4939 7860 6952 2021 20
year

interest coverage
Unilever Plc GSK Plc
17.72

11.41

8.73
7.91
ratio

2021 2020

year
Net margin
Unilever Plc GSK Plc

18.73%
11.97%

2020
year

age
c
11.41

8.73

2020
Total Revenue 52,444,000 50,724,000 51,980,000 50,982,000
Cost of Revenue 30,259,000 28,684,000 29,102,000 28,769,000
Gross Profit 22,185,000 22,040,000 22,878,000 22,213,000
Operating Expense 12,549,000 12,673,000 14,170,000 9,678,000
Operating Income 9,636,000 9,367,000 8,708,000 12,535,000
Net Non Operating Interest Income Expense -361,000 -480,000 -569,000 -494,000
Pretax Income 8,556,000 7,996,000 8,289,000 12,383,000
Tax Provision 1,935,000 1,923,000 2,263,000 2,575,000
Net Income Common Stockholders 6,049,000 5,581,000 5,625,000 9,389,000